Iman Maher Mansour

Iman Maher Mansour

Auto-generated profile, based on publicly available information

Iman Maher Mansour

Department of Clinical & Chemical pathology, Kasr Al-Ainy hospital, Faculty of medicine, Cairo University, Cairo, 11562, Egypt

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2016 in Hematology
Verified
Journal Article
Closed access
IMIman Mansour
Iman Mansour
RZRania Zayed
Rania Zayed
FSFadwa Said
Fadwa Said
LLLamyaa Abdel Latif
Lamyaa Abdel Latif
Background and objectives: The microenvironment of acute myeloid leukemia (AML) is suppressive for immune cells. Regulatory T cells (Tregs) have been recognized to play a role in helping leukemic cells to evade immunesurveillance. The mesenchymal stem cells (MSCs) are essential contributors in immunomodulation of the microenvironment as they can promote differentiation of Tregs via the indoleamine 2,3-dioxygenase (IDO) pathway. The aim of the present work was to evaluate the expression of IDO in bone marrow derived MSCs and to study its correlation to percentage of Tregs. Methods: Thirty-seven adult bone marrow samples were cultured in appropriate culture medium to isolate MSCs. Successful harvest of MSCs was determined by plastic adherence, morphology, and positive expression of CD271 and CD105; negative expression of CD34 and CD45 using flowcytometry. MSCs were examined for IDO expression by immunocytochemistry using anti-IDO monoclonal antibody. CD4+ CD25+ cells (Tregs) were measured in bone marrow samples by flowcytometry. Results: MSCs were successfully isolated from 20 of the 37 bone marrow samples cultured. MSCs showed higher expression of IDO and Tregs percentage was higher in AML patients compared to control subjects (P = 0.002 and P < 0.001, respectively). A positive correlation was found between IDO expression and Tregs percentage (P value = 0.012, r = 0.5). Conclusion: In this study, we revealed an association between high IDO expression in MSCs and elevated levels of Tregs which could have an important role in the pathogenesis of AML, providing immunosuppressive microenvironment.

1 February 2006 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
AEA. El‐Beshlawy
A. El‐Beshlawy
LRL. Ragab
L. Ragab
IYILHAM YOUSSRY
ILHAM YOUSSRY
KYK. Yakout
K. Yakout
HEH. El‐Kiki
H. El‐Kiki
PMP. K. Mistry
P. K. Mistry

1 June 2006 in Laboratory Hematology
Verified
Journal Article
Closed access
AMAzza Mohamed
Azza Mohamed
AIAzza Ibrahim
Azza Ibrahim
MEManal El-Masry
Manal El-Masry
IMIman Mansour
Iman Mansour
MKMervat Khroshied
Mervat Khroshied
RRRaafat Riad
Raafat Riad
Metapress is the fastest-growing resource of expert content online -- Discover more about what interests you, learn new skills, and find inspiration.

1 March 2012 in Laboratory Hematology
Verified
Journal Article
Closed access
AIAzza Mostafa Ibrahim
Azza Mostafa Ibrahim
IMIman Maher Mansour
Iman Maher Mansour
MWManal Michel Wilson
Manal Michel Wilson
DMDoha Abdel-Hamid Mokhtar
Doha Abdel-Hamid Mokhtar
AHAmani Mohamed Helal
Amani Mohamed Helal
HWHanan Mohamed Al Wakeel
Hanan Mohamed Al Wakeel
Metapress is the fastest-growing resource of expert content online -- Discover more about what interests you, learn new skills, and find inspiration.

18 March 2005 in Journal of Perinatology
Verified
Journal Article
Closed access
HAHany Aly
Hany Aly
ABAmal El Beshlawy
Amal El Beshlawy
NBNadia Badrawi
Nadia Badrawi
LMLamiaa Mohsen
Lamiaa Mohsen
EMEman Mansour
Eman Mansour
KPKantilal Patel
Kantilal Patel

1 April 2008 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
AEAmal El-Beshlawy
Amal El-Beshlawy
AMAzza Mostafa
Azza Mostafa
IYILHAM YOUSSRY
ILHAM YOUSSRY
HGHala Gabr
Hala Gabr
IMIman M. Mansour
Iman M. Mansour
IHIbtissam R. Hussein
Ibtissam R. Hussein
The splicing mutation in intron 1 of beta-globin gene (IVS1-110) is the most common mutation in Egyptian thalassemics that causes aberrant splicing of pre-mRNA and deficient beta-globin chain synthesis. Antisense oligonucleotides (ASONs) are compounds that redirect pre-mRNA splicing and modify gene expression. Our aim was ex vivo correction of the aberrant splicing of beta-globin110 pre-mRNA by ASON against the 3' aberrant splice site. Peripheral blood mononuclear cells of 10 thalassemic patients with IVS1-110 mutation were duplicated and 1 was treated with 20 micromoL/mL morpholino ASON targeted against the 3' aberrant splice site. The level of total hemoglobin (Hb), fetal Hb, and mRNA were estimated in the duplicate samples. Five cases (50%) showed correction with ASON treatment, of which 2 cases showed the appearance of corrected mRNA band with absence of the aberrant band and 3 cases showed an increased ratio of the corrected to the aberrant mRNA band from 2:1 to 3:1, and 4:1. The total Hb showed significant increase in the 5 corrected cases. In conclusion, ASON can restore correct splicing of beta-globin pre-mRNA leading to correct gene product in cultured erythropoietic cells. These results suggest the applicability of ASON for the treatment of thalassemia.